(19)
(11) EP 3 474 924 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.05.2021 Bulletin 2021/21

(45) Mention of the grant of the patent:
07.04.2021 Bulletin 2021/14

(21) Application number: 17735352.1

(22) Date of filing: 26.06.2017
(51) International Patent Classification (IPC): 
A61M 5/00(2006.01)
A61M 5/315(2006.01)
 A61M 5/31(2006.01)
A61M 25/02(2006.01)
(86) International application number:
PCT/US2017/039260
(87) International publication number:
WO 2018/005353 (04.01.2018 Gazette 2018/01)

(54)

SYRINGE STABILIZER

SPRITZENSTABILISATOR

STABILISATEUR DE SERINGUE.

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 27.06.2016 US 201662354964 P

(43) Date of publication of application:
01.05.2019 Bulletin 2019/18

(60) Divisional application:
21167025.2

(73) Proprietor: Takeda Pharmaceutical Company Limited
Osaka-shi, Osaka (JP)

(72) Inventors:
  • ARIAGNO, Scott, Richard
    Palatine IL 60067 (US)
  • MURISET, Angela, Teresa
    Hoffmann Estates IL 60192 (US)
  • ROUSH, Daniel, Edward
    Niles IL 60714 (US)
  • ALEXANDER, Denise, A.
    Naperville IL 60564 (US)
  • GIBSON, Madeleine, Clare
    Madison WI 53703 (US)
  • CHEN, Gin-Fu
    Chicago IL 60607 (US)

(74) Representative: Bettridge, Paul Sebastian 
Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A1-01/62328
US-A- 4 737 151
 WO-A1-2012/159211
US-A1- 2015 088 075
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).